Basimglurant

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

Lua error in Module:Infobox at line 314: malformed pattern (missing ']').

Basimglurant (INN) (code names RG-7090, RO4917523) is a negative allosteric modulator of the mGlu5 receptor which is under development by Roche for the treatment of treatment-resistant depression (as an adjunct) and fragile X syndrome.[1][2] As of August 2014, it is in phase II clinical trials for both of these indications.[1][2]

See also

References

<templatestyles src="Reflist/styles.css" />

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
  1. ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
Retrieved from "https://infogalactic.com/w/index.php?title=Basimglurant&oldid=713194959"